Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Rigel Pharmaceuticals has demonstrated strong financial performance in recent quarters, with a notable revenue beat in Q3 2024. The company reported revenue of $55.3 million, surpassing the ...

Written and directed by Maria Rigel, the movie will have its world premiere in the Proxima lineup of the Karlovy Vary International Film Festival 2025.

Rigel Pharmaceuticals (RIGL) is a stock many investors are watching right now. RIGL is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. Value investors also love the P ...

Title: Efficacy and Safety of Pralsetinib in Patients with Advanced RET-fusion-positive NSCLC: Final Data from the Phase 1/2 ARROW Study Presenter: Eunice S. Wang, M.D. A post-hoc analysis of ...

Presenter: Eunice S. Wang, M.D. A post-hoc analysis of the pivotal cohort from the Phase 1/2 study evaluated outcomes in patients with R/R mIDH1 AML who received olutasidenib after either 1-2 or ...

Two adults and a 5-year-old were taken to a local hospital for treatment after a two-vehicle accident in Lamar County late ...

The fest that also announced its juries "has always addressed political issues through powerful individual stories, fully ...

The Karlovy Vary Film Festival has announced its full 2025 lineup, minus one Iranian title which will be announced at a later ...

Syzygy Plasmonics has announced the start of front-end engineering and design (FEED) with Kent for NovaSAF 1, which is ...